Remeglurant (
INNTooltip International Nonproprietary Name; developmental code name MRZ-8456) is a
drug which acts as a
selectiveantagonist of the
mGlu5 receptor.[1][2][3] It is under development by Merz Pharmaceuticals for the treatment of
drug-induced dyskinesia but no development has been reported since at least 2016.[3]
^US 7985753, Danysz W, Dekundy A, Hechenberger M, Henrich M, Jatzke C, Nagel J, Parsons CG, Weil T, Fotins J, Gutcaits A, Kalvinsh I, Zemribo R, Kauss V, "Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators.", issued 4 August 2006, assigned to Merz Pharmaceuticals GmbH